DE1450454U - - Google Patents

Info

Publication number
DE1450454U
DE1450454U DENDAT1450454D DE1450454DU DE1450454U DE 1450454 U DE1450454 U DE 1450454U DE NDAT1450454 D DENDAT1450454 D DE NDAT1450454D DE 1450454D U DE1450454D U DE 1450454DU DE 1450454 U DE1450454 U DE 1450454U
Authority
DE
Germany
Prior art keywords
dte
dea
den
ç3tlete
xnspruoh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1450454D
Other languages
German (de)
English (en)
Publication of DE1450454U publication Critical patent/DE1450454U/de
Active legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DENDAT1450454D Active DE1450454U (cg-RX-API-DMAC7.html)

Publications (1)

Publication Number Publication Date
DE1450454U true DE1450454U (cg-RX-API-DMAC7.html)

Family

ID=758234

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1450454D Active DE1450454U (cg-RX-API-DMAC7.html)

Country Status (1)

Country Link
DE (1) DE1450454U (cg-RX-API-DMAC7.html)

Similar Documents

Publication Publication Date Title
DE1450454U (cg-RX-API-DMAC7.html)
US6919370B2 (en) Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
Sessink et al. Evaluation of the PhaSeal hazardous drug containment system
Begley et al. Lenacapavir sustained delivery formulation supports 6-month dosing interval
US20190145741A1 (en) Tactical wall panel, assembly and methods of deployment and use
Saunders et al. The State Records of North Carolina
Kanj et al. The battle against fungi: lessons in antifungal stewardship from COVID 19 times
Schneider et al. Management of HCV-associated liver cirrhosis
Gaddoni et al. Contact dermatitis among decorators and enamellers in hand-made ceramic decorations.
DE1517474U (cg-RX-API-DMAC7.html)
Hoesley et al. Overview of oral azole drugs as systemic antifungal therapy
Murskyj Disseminated histoplasmosis after vedolizumab treatment for ulcerative colitis
Mccorquodale et al. Helicopter immobilization of elk in southcentral Washington
ES2304163T3 (es) Solucion inyectable esteril estable, lista para usar, de 9-((1,3-dihidroxipropan-2-iloxi)metil)-2-amina-1h-purin-6(9h)-ona; sistema cerrado para envasar solucion; procedim. eliminar residuos alcalinos cristales de 9-((1,3-dihidroxipropan-2-iloxi)metil)-2-amina-1h-purin-6(9h)-ona.
DE1487257U (cg-RX-API-DMAC7.html)
CN211584289U (zh) 一种新型便于艾滋病人使用的药盒
Prugnard et al. Chemistry and structure-activity relationships of biguanides
KR910016707A (ko) 5-페닐-1h-피라졸-4-프로피온산 유도체, 그 제조 및 사용방법.
林慧 Evaluation of Irinotecan and Trifluridine/Tipiracil as Fourth-line Treatments After Third-line Nivolumab for Advanced Gastric Cancer
Park et al. Primary cutaneous cryptococcosis successfully treated with fluconazole
PL246350B1 (pl) Pochodne kwasu (2,4-diokso-1,3-tiazolidyn-3-ylo)octowego, sposób ich wytwarzania oraz ich zastosowanie medyczne
DE1393185U (cg-RX-API-DMAC7.html)
DE1532219U (cg-RX-API-DMAC7.html)
DE1416562U (cg-RX-API-DMAC7.html)
Glatt Caspofungin was noninferior to amphotericin B for invasive fungal infections in persistent fever and neutropenia and was better tolerated/COMMENTARY